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ABSTRACT: Background. The use of mandibular distraction
osteogenesis (MDO) for tissue replacement after oncologic resection or
for defects caused by osteoradionecrosis has been described but, in
fact, has seen limited clinical utility. Previous laboratory work has shown
that radiation (XRT) causes decreased union formation, decreased
cellularity, and decreased mineral density in an animal model of MDO.
Our global hypothesis is that radiation-induced bone damage is partly
driven by the pathologic depletion of both the number and function of
osteogenic cells. Parathyroid hormone (PTH) is a U.S. Food and Drug
Administration–approved anabolic hormonal therapy that has
demonstrated efficacy for increasing bone mineral density for the
treatment of osteoporosis. We postulate that intermittent systemic
administration of PTH will serve as an anabolic stimulant to cellular
function that will act to reverse radiation-induced damage and enhance
bone regeneration in a murine mandibular model of DO.
Methods. A total of 20 isogenic male Lewis rats were randomly
assigned into 3 groups. Group 1 (XRT-DO, n ¼ 7) and group 2 (XRT-DO-
PTH, n ¼ 5) received a human bioequivalent dose of 70 Gy fractionated
over 5 days. All groups including group 3 (DO, n ¼ 8) underwent a left
unilateral mandibular osteotomy with bilateral external fixator
placement. Four days later, mandibular DO was performed at a rate of
0.3 mm every 12 hours to reach a maximum gap of 5.1 mm. Group 2
was injected PTH (60 lg/kg) subcutaneously daily for 3 weeks following
the start of MDO. On postoperative day 41, all left hemimandibles were
harvested. Micro-CT at 45-lm voxel size was performed and
radiomorphometrics parameters of bone mineralization were generated.
Union quality was evaluated on a 4-point qualitative grading scale.
Radiomorphometric data were analyzed using 1-way ANOVA, and union
quality assessment was analyzed via the Mann–Whitney test. Statistical
significance was considered at p  .05.
Results. Groups 1 and 2 appropriately demonstrated clinical signs of
radiation-induced stress ranging from alopecia to mucositis. Union
quality was significantly higher in PTH-treated XRT-DO animals,
compared with XRT-DO group animals (p ¼ .02). Mineralization metrics,
including bone volume fraction (BVF) and bone mineral density (BMD),
also showed statistically significant improvement. The groups that were
treated with PTH showed no statistical differences in union or
radiomorphometrics when compared with DO in nonradiated animals.
Conclusion. We have successfully demonstrated the therapeutic efficacy
of PTH to stimulate and enhance bone regeneration in our irradiated
murine mandibular model of DO. Our investigation effectively resulted in
statistically significant increases in BMD, BVF, and clinical unions in
PTH-treated mandibles. PTH demonstrates immense potential to treat
clinical pathologies where remediation of bone regeneration is essential.
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INTRODUCTION
The mandible is often included in the radiation field
when treating oral cavity and oropharyngeal squamous
cell carcinoma.1,2 Although the incidence of osteoradio-
necrosis (ORN) has decreased in the last few decades, it
still has remained approximately 5% and remains a debil-
itating late complication of radiation therapy.3 Further-
more, those patients who do develop osteoradionecrosis
may have severe limitations in mandibular function and
are at risk for pathologic fracture. Quality of life is often
affected in patients with ORN, including limitations
related to diet, and altered aesthetics, all of which result
in limitation of social interaction.
Segmental mandibulectomy is required for tumor
invasion into bone or for severe, grade IV, osteoradio-
necrosis that has failed medical management. Recon-
structive options in these cases are limited to osseous
free tissue transfer or to soft tissue in combination with
a reconstruction bar. The superiority of free tissue trans-
fer in preventing plate exposure and wound infection
has been previously reported and has led to increasing
use of the harvest and inset of bony free tissue.4,5 Free
tissue transfer, however, is associated with a longer op-
erative time and has the potential for increased donor
site morbidity. Alternative reconstructive options, which
would engineer autologous bone within the existing
defect, are desirable.
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Distraction osteogenesis (DO) is a form of in vivo tis-
sue engineering whereby new bone formation is stimu-
lated by the gradual separation of 2 osteogenic fronts.6
Distraction osteogenesis has been used most extensively
in the head and neck for congenital mandibular deform-
ities,7 and the use of DO may be a reconstructive option
for tissue replacement after oncologic resection and/or
osteoradionecrosis.
Distraction osteogenesis could have immense therapeu-
tic utility but is a more formidable undertaking in the set-
ting of previously radiated tissue. The effects of ionizing
radiation on the regeneration of bone within a fracture
site include decreased osteocyte number, suppressed
osteoblast activity, and diminished vascularity.8 Direct
cellular impairment and vascular injury are potential
obstacles to successful distraction osteogenesis. Nonethe-
less, a small number of clinical cases and animal studies
have reported using mandibular distraction osteogenesis
following radiotherapy with mixed results.9 Previous stud-
ies in our laboratory have also demonstrated the impair-
ment of optimal bone regeneration in radiated animals
with regard to bone mineralization, biomechanical
strength, and cellularity. Therapeutic adjuncts, therefore,
will be important in improving the success and clinical
utility of postradiation distraction osteogenesis.
Parathyroid hormone (PTH), a major regulator of Ca2þ
homeostasis, can stimulate bone formation and/or resorp-
tion, depending on the mode of administration. Continu-
ous infusions lead to greater bone resorption, whereas
intermittent daily dosing has an anabolic effect and leads
to increased bone mass.10 PTH(1–34) has been shown to
arrest and partially reverse bone loss in animals and
humans,11 and clinical trials have shown its benefit in
osteoporosis.12 Animal studies have also demonstrated
that intermittent PTH(1–34) promotes osteogenesis in
fracture healing and enhances the size and mechanical
properties of calluses.13 Intermittent PTH has also been
shown to increase strength, stiffness, and bone mineral
density (BMD) in a rat model of long bone distraction
osteogenesis.14
Our goal was to investigate the effects of parathyroid
hormone and radiotherapy in a murine model of distrac-
tion osteogenesis using qualitative union assessment and
micro-computed radiomorphometrics. Our hypothesis is
that intermittent systemic administration of PTH will
serve as a stimulant to cellular function that will act to
reverse radiation-induced damage and enhance bone
regeneration. Specific quantitative analysis of bone will
allow us to compare outcomes of radiated animals who
have been treated with those that have not been treated
with PTH. In addition we will gauge the efficacy of PTH
to remediate radiation damage by comparing our results
with those of nonradiated animals who have undergone
distraction osteogenesis alone.
MATERIALS AND METHODS
Experimental groups and model
Twenty 12-week-old male Lewis rats were assigned
randomly to 1 of 3 experimental groups preoperatively:
group 1, rats that would receive preoperative radiation
followed by distraction (n ¼ 7); group 2, rats that would
receive preoperative radiation followed by distraction and
PTH (n ¼ 5); and group 3, rats that would undergo dis-
traction alone (n ¼ 8).
The group 1 and group 2 rats underwent fractionated
irradiation to the left hemimandible followed by a 2-week
recovery period before surgery. All 3 experimental groups
then underwent surgical osteotomy and placement of a
distraction device with the osteotomy gap closed. All 3
groups were then subjected to a 4-day latency period fol-
lowed by distraction 0.3 mm twice daily to a 5.1-mm
total gap width. PTH (60 lg/kg) þ vehicle (0.9NS) were
administered subcutaneously daily to group 2, beginning
the first day of distraction for 21 days. The other 2 groups
received vehicle injections during the same length of
time. All 3 experimental groups underwent 28 days of
regenerate consolidation after the last day of distraction
(see Figure 1).
Preoperative animal care
The male Lewis rats weighed approximately 350 g and
were housed 3 animals per cage in a pathogen-free, re-
stricted-access facility on arrival to our laboratory. Group
1 and group 2 animals were fed hard chow and water
without restriction during a 3-day acclimation period and
during radiotherapy. Group 3 animals were fed hard chow
and water without restriction during the 3-day acclimation
period. The diet was changed in all groups to moist chow
4 days preoperatively. All animal procedures were per-
formed in accord with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals and
approved by the University of Michigan Animal Care and
Use Committee.
Irradiation
Radiotherapy was performed at the Irradiation Core of
the University of Michigan Cancer Center. Radiotherapy
was delivered with a Phillips RT250 orthovoltage unit
(250 kV, 15 mA; Kimtron Medical, Woodbury, CT). Do-
simetry was carried out using an ionization chamber con-
nected to an electrometer system. The group 1 and group
2 rats were irradiated after being anesthetized with iso-
flurane. Induction was begun at 4%, after which the rat
was maintained at 1.5% They were placed right-side
down, to expose the left mandible. A lead shield was
used to protect the remainder of the animal. A total of 35
Gy of radiation was delivered per rat in 5 fractions over 5
FIGURE 1. Timeline from acclimation, radiation, surgery, distraction,
consolidation, and then euthanasia after POD#40. [Color figure can
be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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days at a rate of 7 Gy per fraction, which is the bioequi-
valent dose of 70 Gy in humans.15
Surgical procedure
Our surgical distraction procedure has been described
and published before,16 but briefly, preoperatively, ani-
mals were given prophylactic gentamicin (5 mg/kg, sub-
cutaneously) 1 hour prior to incision. In addition, bupre-
norphine (0.03 mg/kg, subcutaneously) and lactated
Ringer’s solution (25 mL/kg, subcutaneously) were given
for pain control and hydration, respectively. General an-
esthesia was induced with an isoflurane/oxygen mixture,
and the animal’s ventral submental hair was shaved in
preparation for surgery. The animal was then placed in a
supine position and prepped and draped in a sterile fash-
ion, and the procedure commenced under sterile
conditions.
A 1.5-cm midline incision was placed ventrally from
the anterior submentum. Skin flaps were elevated, expos-
ing the anterolateral mandible. After predrilling holes
bilaterally 0.5 mm posterior to the symphysis, a 1.5-inch
stainless steel threaded pin was inserted transversely
across the anterior mandible, with the ends brought exter-
nally through the skin, creating the anterior portion of our
modified external fixator/distraction device. On each side,
an 8-mm incision was made through the masseter, down
to and in line with the inferior border of the mandible,
approximately 2.5 mm anterior to the angle. After predril-
ling 2 mm superior to the inferior border and 4 mm ante-
rior to the angle, bilateral stainless still threaded pins
were inserted buccal-to-lingual and secured with our cus-
tom titanium washer and nut. The pin ends were brought
externally through the skin for the posterior fixator place-
ment with titanium cap screws. The right mandible was
rigidly fixed, whereas the left mandible was fixed with a
distraction screw for postoperative manipulation.
A vertical osteotomy was made in the left hemimandi-
ble approximately 2 mm anterior to the titanium washer
using a 10-mm micro reciprocating blade (Stryker, Por-
tage, MI) attached to a power saw (Stryker). The osteot-
omy extended from the inferior mandible border superi-
orly to the sigmoid notch along the anterior aspect of the
coronoid process. The osteotomy edges were reduced and
then resecured with the fixator (see Figure 2). The wound
was irrigated, hemostasis verified, soft tissue approxi-
mated using 4-0 Vicryl (Ethicon, Inc., Somerville, NJ)
suture, and the midline incision closed with staples.
Postoperative animal care
All experimental groups were housed 1 animal per
cage and fed moist chow with Hill’s high-calorie diet
(Columbus Serum, Columbus, OH) and water without
restriction. Both groups of animals were given 2 postop-
erative doses of gentamicin (5 mg/kg subcutaneously ev-
ery 12 hours). Buprenorphine was continued (0.03 mg/kg)
with 10 mL of lactated Ringer’s solution subcutaneously
every 12 hours through postoperative day 4 and as
needed thereafter. Bactrim was given with the moist
chow postoperatively until euthanized prophylactically
against postoperative wound infection. Pin care was per-
formed with Silvadene (Monarch Pharmaceuticals, Inc.,
Bristol, TN) every other day. Maxillary incisors were
clipped weekly because of overgrowth from crossbite and
staples removed at postoperative day 10. Weights were
monitored daily and diets adjusted as needed.
Distraction protocol
Group 1, group 2, and group 3 animals underwent dis-
traction after 4 days of latency. One 180 clockwise turn
of the distraction screw corresponded to a 0.3-mm separa-
tion of the osteotomy fronts. A total of 17 half-turns were
performed every 12 hours, resulting in a 5.1-mm distrac-
tion gap. No analgesic or sedation was required during
the distraction. After 28 days of consolidation, all animals
were euthanized (postoperative day 41).
Microcomputed tomography
Mandibles were harvested and then scanned at 45-lm
resolution with micro–CT. The region of interest was
defined as a distance measuring 2 mm after the third
molar corresponding to the surgical site of the osteotomy
and set gap distance. Only bone within each section was
selected. In cases in which a part of the incisor or canal
was present, the tooth, the canal, and the periodontal tis-
sue were excluded for uniformity. Analysis of the left
hemimandible region of interest was then performed with
MicroView 2.2 software (GE Healthcare, Milwaukee,
WI). Contours were defined highlighting the region of in-
terest using the spline tool in MicroView.
Each voxel is assigned a grayscale value in Micro-
View; to calculate densities, it uses an algorithm that con-
verts the grayscale value of each voxel to mineral con-
tent. Mature bone was thresholded at 2000 HU, whereas
newly formed bone was thresholded at 800 HU. Our
range for newly remodeled bone therefore extended from
800 to 2000 HU, as is the protocol in our laboratory
based on previous studies, and this has been supported
with histomorphometric correlation.15,17 BMD was
defined as the total mineral content of newly remodeled
bone divided by the total volume of the region of interest,
the distraction gap. Bone volume fraction (BVF) was
defined as the volume of newly remodeled bone divided
by the total volume of the region of interest, which
included air and soft tissue.
FIGURE 2. Each animal underwent bilateral external fixator
placement and left mandible osteotomy. [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
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Union quality
Regenerate integrity was qualitatively assessed on a 4-
point grading scale by 3 independent reviewers. In all
cases, the grades were unanimous. A grade of 1 indicated
complete nonunion, with no connection between the 2
fronts of the distracted region. A grade of 2 indicated fi-
brous union, with only fibrous tissue and no bone
between the 2 fronts of the distracted region. A grade of
3 indicated bony bridging, with between 1 and 25% of
the connection between to the fronts of the distracted
region comprised of bone. A grade of 4 indicated bony
union, with over 25% of the connection between the
fronts of the distracted region comprised of bone.
Statistical analysis
One-way analysis of variance (ANOVA) was used for
analyzing BMD and BVF (SPSS version 16.0; SPSS, Inc.,
Chicago, IL). Due to the noncontinuous nature of union
grading, a Mann–Whitney U statistical analysis test was
used to analyze these data. Results were accepted as stat-
istically significant at a value of p < .05.
RESULTS
Animals in all 3 treatment groups tolerated the proto-
col. Animals treated with radiation demonstrated expected
clinical signs of radiation treatment, ranging from alope-
cia to mucositis. Groups were assigned a priori and the
variable number in each group reflects expiration during
anesthetic for the procedure and/or postoperative weight
loss requiring euthanasia. Postoperatively, animals
included in the study lost weight initially but then gained
weight once distraction was complete and in the consoli-
dation phase. None of the animals experienced device dis-
lodgement, and the fixators remained stable until the ani-
mals were euthanized on postoperative day 41.
Gross examination of the left hemimandibles showed
significant qualitative differences in union quality. The
overall union quality assessment was worst in the XRT-
DO animals (group 1; median grade, 2; range, 1–3) and
best in the DO alone animals (group 3; median grade, 4;
range, 2–4). Interestingly, there was no statistical differ-
ence in union quality between radiated distracted animals
treated with PTH (XRT-PTH-DO; group 2; median grade,
3; range, 2–4) and the nonradiated DO alone (group 3)
animals. The union quality of XRT-DO animals (group 1;
mean grade, 1.875), however, was significantly worse
than the nonradiated (group 3) animals and animals
treated with PTH (group 2; mean grade, 3.125) (p ¼ .02).
In other words, there was more evidence of union in the
radiated animals treated with PTH (XRT-DO-PTH, group 2)
and nonradiated animals (DO alone, group 3) compared
with the radiated distracted group (XRT-DO, group 1) (see
Figure 3).
The radiomorphometrics, generated from the micro–CT
data, which included BMD and BVF, was similar to gross
examination and union quality. The group treated with
radiation before DO without PTH showed a statistically
significant decrease in BMD. However, despite being
treated with radiation, the group treated with PTH (XRT-
PTH-DO) demonstrated maintenance of BMD compared
with the nonradiated DO alone group. In analyzing the
BMD, the radiated distraction group (XRT-DO, 452 mg/
mL) showed a statistically significant decrease in density
compared with both the nonradiated group (DO alone,
552 mg/mL, p ¼ .017) and the PTH-treated group (XRT-
PTH-DO, 558 mg/mL, p ¼ .009). There was no signifi-
cant difference between the nonradiated group and the
PTH group (552 mg/mL vs 558 mg/mL, p ¼ .91) (see
Figure 4). Micro–computed tomographic analysis of BVF
showed a significant decrease in the percentage of bone
in our radiated group (51.19%) compared with the
FIGURE 3. Lingual and buccal views from gross specimens from each experimental group: the specimen on the left underwent distraction alone
(group 3), the middle group underwent radiation and distraction (group 1), and the group on the right underwent radiation/distraction þ parathyroid
hormone (PTH) (group 2). There were visible differences between the 3 groups, but the XRT-DO-PTH appears more similar to the nonradiated,
distraction alone specimen. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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nonradiated (72.46%, p < .001) and PTH-treated groups
(69.84%, p < .001). There was no difference between the
nonradiated group and the PTH group (72.46% vs
69.84%, p ¼ .97) (see Figure 5). Essentially, the addition
of PTH to radiated-distracted animals normalized both
metrics (BMD and BVF) toward the nonradiated group
(DO alone, group 3).
DISCUSSION
Radiation causes injury to cell populations, alters cytokine
expression profiles, and leads to hypovascular and hypoxic
conditions.8 In vitro studies on irradiated mouse osteoblasts
demonstrate decreased cell proliferation and a dose-depend-
ent sustained reduction in collagen production compared
with controls.18 Radiation has also previously been shown to
decrease bone quality, and BMD in particular.19
Mandibular distraction osteogenesis requires the differ-
entiation and proliferation of osteoprogenitor cells after
organization of the initial surgical wound.20 It has previ-
ously been shown that radiation results in poorer regener-
ate outcomes in mandibular distraction osteogenesis with
regard to cellularity, radiomorphometrics, and biomechan-
ical strength.17,21,22 Our findings of poorer union quality
and decreased BMD and BVF in the radiated, distracted
animals (group 1) are consistent with these previous
outcomes.
The finding that PTH improves regenerate outcomes in
terms of union quality, BMD, and BVF in radiated ani-
mals that underwent mandibular distraction osteogenesis
is an entirely novel application of PTH therapy. Parathy-
roid hormone (PTH) is the only U.S Food and Drug
Administration–approved therapy that stimulates bone
formation in osteoporotic individuals and has been shown
to reverse loss of BMD and prevent fractures in clinical
trials.12,23 PTH has been shown to increase bone forma-
tion on cancellous, endocortical, and periosteal bone
surfaces. On the cellular level, intermittent PTH promotes
osteoblast differentiation and activation.24 The overall
osteoblast number is also increased by direct PTH activa-
tion of survival signaling over apoptosis.25 Interestingly,
it has been shown that radiation reduces osteoblast num-
ber and function. It is possible that these particular effects
of radiation may be specifically negated by PTH. The
improvement in cell number and function by PTH ther-
apy explains the normalization of radiated and distracted
bone in terms of the radiomorphometric measures of den-
sity and percentage of bone.
Our findings would support the potential of PTH to be
used clinically to treat pathologic situations where reme-
diation of bone regeneration is essential. The addition of
PTH as a therapeutic intervention during postradiation
mandibular DO would make this a more feasible and
potentially more successful reconstructive option in onco-
logic resections or in reconstruction for defects after sur-
gical treatment of osteoradionecrosis. The therapeutic ef-
ficacy of PTH to stimulate and enhance bone
regeneration in our irradiated model of distraction osteo-
genesis suggests that its clinical application would result
in an improvement in the mandibular union quality.
The use of PTH might even be extrapolated to cases of
osteoradionecrosis that may have the chance for therapeu-
tic salvage by intermittent PTH dosing. Interestingly, 2
cases have been reported in which terparatide (PTH
1–34) has successfully resolved osteonecrosis of the jaw
caused by bisphosphonates.26,27 Nonsurgical salvage of
previous medical failures could be an exciting approach
for PTH to remedy difficult cases of osteoradionecrosis.
We plan to further examine the effects of PTH on post-
radiation distraction osteogenesis with other outcome
measures, including quantitative histomorphometrics, to
further confirm our hypothesis. In addition to the ability
of PTH to ossify a tissue-engineered construct, we also
plan to examine its potential vasculogenic effects during
MDO. Importantly, biomechanical strength testing of
PTH-treated mandibles is also currently under way, given
that this will be the most relevant outcome measure for
FIGURE 4. Bone mineral density is the total mineral content within a
region of interest divided by the entire volume within that region of
interest. The radiated distraction group showed a statistically
significant decrease in density compared with both the nonradiated
group and the PTH-treated group. Of note, there was no significant
difference between the nonradiated group and the PTH group,
illustrating the efficacy of PTH in normalizing this metric. [Color
figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
FIGURE 5. Bone volume fraction is the percentage of the region of
interest that is defined as bone, as opposed to soft tissue or air.
There is a significant decrease in the percentage of bone in the
radiated/distracted group compared with the nonradiated and PTH-
treated groups. There is no difference between the nonradiated
group and the PTH group. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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clinical and functional purposes. Finally, we plan to study
PTH in combination with other therapies, with the antici-
pation that multiple therapies may prove to be synergistic
in improving bone regeneration after radiation. We are
hopeful that the use of these innovative therapeutic strat-
egies could accelerate the translation of our work from
the bench to the bedside to provide novel remedies for
both surgeons and their patients suffering from devastat-
ing radiation-related maladies.
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